Michel S.

Biography

Dr. Michel Spagnol serves as Chairman and Chief Executive Officer at Novasep Inc. Mr. Spagnol has been the Chief Executive Officer of Novasep Holding SAS since June 25, 2013. Dr. Spagnol served as President of Novasep Holding SAS since June 25, 2013. Dr. Spagnol is a Proven Business Leader with core expertise in leading contract manufacturing of active pharmaceutical ingredients and more broadly, strong experience in using and developing innovative technologies to address needs of customers in fine chemicals and life sciences fields. He served as President and Chief Technology Officer of Shasun Chemicals & Drugs Limited and Shasun Pharmaceuticals Ltd. Prior to Shasun, he spent his career at Rhodia in Lyon and Cranbury (NJ, USA) where he progressed first in technical R&D leadership roles and subsequently transitioned to business development as a Sales and Marketing Vice President of Rhodia Pharma Solutions. He joined the Rhône-Poulenc group (renamed Rhodia in 1998) in Lyon in 1993 where he successively held various senior managerial positions, with a strong focus in research management and then in sales and marketing functions. From 2000 to 2002, he served as Innovation and Development Vice President at Rhodia Life Sciences Systems in Lyon. He served as Sales and Marketing Vice President at Rhodia Pharma Solutions since 2003. In 2006, following the divestment of Rhodia Pharma Solutions to Shasun, he joined the new company as President and Chief Technology Officer. He successfully implemented a growth and profitable strategy for its Global CRAMS business. He has been Chairman of Supervisory Board of Novasep Holding SAS since March 2014 and also serves as its Member of Supervisory Board. He graduated as a Chemical Engineer from the Mulhouse Engineering School (ENSC Mulhouse) in 1987. He holds an Master and PhD from Stanford University in Chemistry.        

Research Interest

business